Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus

NCT04113239 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-07-20

No results posted yet for this study

Summary

A case-control study to identify microbiome and genetic differences between healthy people and patients with incident type 2 diabetes mellitus.

Conditions

  • Diabetes Mellitus, Type 2
  • Metagenome
  • Genetic Predisposition

Interventions

DIAGNOSTIC_TEST

16S rRNA gene sequencing

Taking a stool sample for gut microbiome DNA sequencing

GENETIC

DNA-microarray genotyping

Taking a saliva sample for genotyping

Sponsors & Collaborators

  • Atlas Biomed

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-27
Primary Completion
2021-10-20
Completion
2021-11-25

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04113239 on ClinicalTrials.gov